Peer-refereed Papers

 

           2019

Schönfeld, T., Heineman, A., Schulz, M., Gradl, G., Andresen-Streichert, H., Müller, A. and  Iwersen-Bergmann, S.:
POST-MORTEM ANALYSIS OF PRESCRIPTION OPIOIDS - A FOLLOW-UP EXAMINATION BY LC-MS/MS WITH FOCUS ON FENTANYL.
Forens. Sci. Int. 2019; 
305: 109970 [DOI: 10.1016/j.forsciint.2019.109970]. Epub October 9, 2019. 
Forens Sci Int       PubMed   

Said, A., Ganso, M., Freudewald, L. and Schulz, M.:
Trends in dispensing oral emergency contraceptives and safety issues: 
a survey of German community pharmacists. 

Int. J. Clin. Pharm. 2019; [DOI: 10.1007/s11096-019-00911-6]. Epub September 28, 2019. 
IJCP   PDF   Suppl. Material   PubMed    

Hofmann, G. A., Gradl, G., Schulz, M., Haidinger, G., Tanew, A. and Weber, B.:
The frequency of photosensitizing drug dispensings in Austria and Germany: A coRRELATION WITH THEIR PHOTOSENSITIZING POTENTIAL BASED ON PUBLISHED LITERATURE.  
J. Eur. Acad. Dermatol. Venereol. 2019; [DOI: 10.1111/jdv.15952]. Epub September 14, 2019. 
PubMed     Wiley      

Schulz, M., Griese-Mammen, N., Anker, S.D., Koehler, F., Ihle, P., Ruckes, C., Schumacher, P.M., Trenk, D., Böhm, M. and Laufs, U. 
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial.
Eur. J. Heart Fail. 2019; 21 (8): 1012–1021 [DOI: 10.1002/ejhf.1503). Epub May 25, 2019.  
PubMed     EJHF     PDF     Suppl. Material   

Schulz, M., Griese-Mammen, N., Böhm, M. and Laufs, U.:
Letter on ‘Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': REPLY.
Eur. J. Heart Fail. 2019; [DOI: 10.1002/ejhf.1613]. Epub September 16, 2019.
EJHF   PubMed   

Eickhoff, C., Müller, U., Strunz, A.K., Seidling, H.M., Lampert, A., Felberg, M., Breiholz, S.,
Klintworth, D. 
and Schulz, M.
Das Projekt PRIMA - Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von Ärzten und Apothekern
[
The PRIMA project - electronically-supported physician-pharmacist co-operation to generate
and update medication plans in Germany].
Dtsch. Med. Wochenschr. 
2019; 144 (18): e114–e120 [DOI: 10.1055/a-0859-5862]. Epub March 29, 2019. 
PubMed      PDF 


Ihle, P., Krueger, K., Schubert, I. Griese-Mammen, N., Parrau, N., Laufs, U. and Schulz, M.
Comparison of different strategies to measure medication adherence via claims data in patients with chronic heart failure
Clin. Pharmacol. Ther. 
2019; 106 (1): 211–218 [DOI: 10.1002/cpt.1378]. Epub January 29, 2019. 
PubMed      PDF  

Breiholz, S., Griese-Mammen, N., Krueger, K., Schaefer, M. and Schulz, M.
Acceptance of a Medication Refill Reminder Service in GERMAN Community
Pharmacy Practice.

Pharmazie 2019; 74 (3): 186–190 [DOI: 10.1691/ph.2019.8669]. 
PubMed   

Katzman, J., Mahfoud, F., Böhm, M., Schulz, M. and Laufs, U.:
ASSOCIATION OF MEDICATION ADHERENCE AND DEPRESSION WITH CONTROL OF LDL CHOLESTEROL AND BLOOD PRESSURE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK.
Patient Prefer. Adherence 2019; 13: 9–19. [DOI: 10.2147/PPA.S182765]. Epub December 18, 2018.
PubMed    PDF   


2018

Said, A., Goebel, R., Ganso, M., Zagermann-Muncke, P. and Schulz, M.:
Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists.
Health Policy. 
2018; 122 (12):1302–1309 [DOI: 10.1016/j.healthpol.2018.09.005]. Epub September 13, 2018. 
PubMed    


Gradl, G., Teichert, M., Kieble, M., Werning, J. and Schulz, M.:
COMPARING OUTPATIENT ORAL ANTIBIOTIC USE IN GERMANY AND THE NETHERLANDS FROM 2012 TO 2016.
Pharmacoepidemiol. Drug Saf. 2018; 27 (12): 1344–1355 [DOI: 10.1002/pds.4643]. Epub Sept 28, 2018. 
PubMed    PDF   

Müller, U., Schulz, M., and Mätzler, M.:
Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung der Arzneimitteltherapiesicherheit. Die Arzneimittelinitiative Sachsen-Thüringen (ARMIN)
[Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting. The “Arzneimittelinitiative Sachsen-Thüringen” (ARMIN)]. 

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 
2018; 61 (9): 11191128 
[DOI: 10.1007/s00103-018-2780-5]. Epub July 30, 2018. 

             PubMed    PDF    

Dormann, H., Maas, R., Eickhoff, C., Müller, U., Schulz, M., Brell, D. and Thürmann, P.: 
ERPROBUNG DES BUNDESEINHEITLICHEN MEDIKATIONSPLANS IN DER PRAXIS: DIE PILOTPROJEKTE METROPOLMEDIPLAN 2016, MODELLREGION ERFURT UND PRIMA 
[Testing the standardized medication plan: the pilot projects MetropolMediplan 2016, model region Erfurt and PRIMA]. 
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 
61 (9): 10931102 [DOI: 10.1007/s00103-018-2789-9]. Epub July 25, 2018. 

             PubMed   PDF  


Laufs, U., Griese-Mammen, N., Krueger, K., Wachter, A., Anker, S.D., Koehler, F., Rettig-Ewen, V., Botermann, L., Strauch, D., Trenk, D., Böhm, M. and Schulz, M.:
PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial and results of the pilot study.
Eur. J. Heart Fail. 2018
20 (9): 1350–1359 [DOI: 10.1002/ejhf.1213]. Epub May 30, 2018.  

             PubMed     EJHF   PDF   


Weißenborn, M., Schulz, M., Kraft, M., Haefeli, W.E. and Seidling, H.M. :
Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische Übersicht
[Potential benchmarks for successful interdisciplinary collaboration projects in Germany: a systematic review].
Gesundheitswesen 2018; [DOI: 10.1055/a-0592-7184]. Epub June 21, 2018.  
PubMed    Gesundheitswesen 


2017

Felberg, M., Reckers, K., Schulz, M. and Scherneck, S.:
DER DIABETOLOGISCH QUALIFIZIERTE APOTHEKER DDG. EVALUATION EINER PRAXISORIENTIERTEN INTENSIV-FORTBILDUNG
[Community pharmacist care of patients with diabetes: opportunities and limitations].
Med. Monatsschr. Pharm. 2017; 40 (11): 496
501.  


Botermann, L., Wachter, A., Monzel, K., Krueger, K., Ewen, S., Mahfoud, F., Griese-Mammen, N.,
Schulz, M. and Laufs, U.:
Do patients with diabetes type 2 or chronic heart failure understand
a medication plan
?
Pharmazie 2017; 
72 (12): 764–768 [DOI: 10.1691/ph.2017.7773].  
PubMed    


Krueger, K., Griese-Mammen, N., Schubert, I., Kieble, M., Botermann, L., Laufs, U., Kloft, C. and Schulz, M.: 
IN SEARCH OF A STANDARD WHEN ANALYZING MEDICATION ADHERENCE IN PATIENTS WITH HEART FAILURE USING CLAIMS DATA: A SYSTEMATIC REVIEW.
Heart Fail. Rev. 2018; 23 (1): 63
–71 [DOI: 10.1007/s10741-017-9656-x]. Epub October 9, 2017. 

            PubMed     Full text

Schulz, M.
et al. / BÄK, KBV, AWMF, AMK et al. (eds.):
National Disease Management Guideline CHRONIC HEART FAILURE
(Nationale VersorgungsLeitlinie [NVL] chronische Herzinsuffizienz).
2nd edition 2017


2016


Schulz, M., Goebel, R., Schumann, C. and Zagermann-Muncke, P.:
Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer].
Pharm. Pract. 2016; 14 (3): 828 [DOI:
10.18549/PharmPract.2016.03.828]
PubMed     Full text 

Custodis, F., Rohlehr, F., Wachter, A., Böhm, M., Schulz, M. and Laufs, U.:
Medication knowledge of patients hospitalized for heart failure at admission and after discharge.
Patient Prefer. Adherence 2016; 10: 23332339 [DOI: 10.2147/PPA.S113912]

             PubMed     Full text 

Gradl, G., Krieg, E.-M. and Schulz, M.:
EVALUATION OF PHARMACEUTICAL CONCERNS IN GERMANY: FREQUENCY AND POTENTIAL REASONS.
Pharm. Pract. 2016; 14 (3):
786 [DOI: 10.18549/PharmPract.2016.03.786]. 
PubMed     Full text     Suppl. Material  

Schulz, M., Krueger, K., Schuessel, K., Friedland, K., Laufs, U., Müller, W.E. and Ude, M.:
MEDICATION ADHERENCE AND Persistence according to DIFFERENT antihypertensive drug classES: A RETROSPECTIVE  cohort STUDY of 255,500 patients.
Int. J. Cardiol. 2016; 220: 668–676 [DOI: 10.1016/j.ijcard.2016.06.263]. Epub June 29, 2016.
PubMed     IJC     Full text   

Ganso, M., Goebel, R., Melhorn, S., Schrenk, D. and Schulz, M.:
Lipidpneumonie durch LIPID-haltige Nasensprays und -tropfen
[Lipoid pneumonia associated with lipid-containing nasal sprays and nose drops].
Laryngo-Rhino-Otol. 2016; 95 (8): 534–539 [DOI:
 10.1055/s-0042-108445]. Epub August 9, 2016.
PubMed     Full text 

Botermann, L., Monzel, K., Krueger, K., Eickhoff, C., Wachter, A., Kloft, C., Laufs, U. and
Schulz, M.:
evaluating  PATIENTS’ COMPREHENSIBILITY of a standardized medication plan.
Eur. J. Clin. Pharmacol. 2016; 72 (10): 1229
1237 [DOI: 10.1007/s00228-016-2082-5]. Epub June 15, 2016.
PubMed     EJCP


Botermann, L., Krueger, K., Eickhoff, C., Kloft, C. and Schulz, M.:
PATIENT’S HANDLING OF A STANDARDIZED MEDICATION PLAN: A PILOT STUDY AND METHOD DEVELOPMENT.
Patient Prefer. Adherence 2016; 10: 621–630 [DOI: 10.2147/PPA.S96431]. Epub April 22, 2016.
PubMed     Full text

van Mil, J.W.F., W
esterlund, T., Brown, L., Chen, T.F., Henman, M., Hersberger, K.,  McElnay, J. and Schulz, M.:
MEDICAL CARE AND DRUG-RELATED PROBLEMS: DO DOCTORS AND PHARMACISTS SPEAK THE SAME LANGUAGE?
Int. J. Clin. Pharm. 
2016; 38 (2): 191–194, erratum 195; [DOI: 10.1007/s11096-016-0249-x].
Epub January 21, 2016.
PubMed     Full text     Erratum


2015

Krueger, K., Botermann, L., Schorr, S.G., Griese-Mammen, N., Laufs, U. and Schulz, M.:
Age-related medication adherence in patients with chronic heart failure: a systematic literature review.
Int. J. Cardiol. 2015; 184: 728-735 [DOI: 10.1016/j.ijcard.2015.03.042]. Epub March 4, 2015.
Abstract IJC   PubMed
Full text          Suppl. material

Schulz, M., Meins, J., Diemert, S., Zagermann-Muncke, P., Goebel, R., Schrenk, D., Schubert-Zsilavecz, M. and Abdel-Tawab, M.:
Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas.
Phytomedicine. 2015; 22 (6): 648
-656 [DOI: 10.1016/j.phymed.2015.03.020]. Epub April 29, 2015.
ScienceDirect   PubMed    Full text 

Hansen, K., Schüssel, K., Kieble, M., Werning, J., Schulz, M., Friis, R., Pöhlau, D., Schmitz, N. and Kugler, J.:
Adherence to disease modifying drugs among patients with multiple sclerosis in Germany: A retrospective cohort study.
PLoS One 2015; 10 (7): e0133279 [DOI: 10.1371/journal.pone.0133279.]. Epub July 27, 2015.
PubMed     Full text



2014

Saverno, K., Gothe, H., Schüssel, K., Biskupiak, J.E., Schulz, M., Siebert, U. and Brixner, D.:
Consideration of International Generic Distribution Policies on Patient Outcomes in the United States and Germany.
Pharmazie 2014; 69 (3): 238
-240 [DOI: 10.1691/ph.2014.3786].
PubMed

Schorr, S.G., Eickhoff, C., Feldt, S., Hohmann, C. and Schulz, M.:
EXPLORING THE potential impact of hospital ward-based pharmacy interns on drug safety.
P
harmazie 2014; 69 (4): 316
-320 [DOI: 10.1691/ph.2014.3848].
PubMed 

Ewen, S., Baumgarten, T., Rettig-Ewen, V., Mahfoud, F., Griese-Mammen, N., Schulz, M., Böhm, M. and Laufs, U.:
Analyses of drugs stored at home by elderly patients with chronic heart failure.
Clin. Res. Cardiol. 2015; 104 (4): 320-327 [DOI: 10.1007/s00392-014-0783-2]. Epub November 6, 2014.
PubMed     Full text 


Fikenzer, K., Knoll, A., Fischer, D., Schulz, M., Böhm, M. and Laufs, U.:
Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und kardialer Dekompensation.
[Poor medication adherence and worsening heart failure - a vicious circle].
Dtsch. Med. Wochenschr. 2014; 139 (47): 2390-2394 [DOI: 10.1055/s-0034-1387391]. Epub November 12, 2014.
PubMed    Full text  



2013

Ude, M., Leuner, K., Schüssel, K., Schulz, M. and Müller, W.E.:
ADHERENCE TO ANTIHYPERTENSIVES: FEASIBILITY OF TWO SELF-REPORT INSTRUMENTS TO INVESTIGATE MEDICATION-TAKING BEHAVIOUR IN GERMAN COMMUNITY PHARMACIES.
Int. J. Pharm. Pract. 2013; 21 (3): 169
-177 [DOI: 10.1111/j.2042-7174.2012.00248.x]. Epub October 29, 2012.
PubMed  

Nicolas, A., Eickhoff, C., Griese, N. and Schulz, M.:
drug-related problems in prescribed medicines IN GermanY at the time OF dispensING.
Int. J. Clin. Pharm. 2013; 35 (3): 476
-482 [DOI: 10.1007/s11096-013-9769-9]. Epub April 20, 2013.
PubMed

Czeche, S., Schüssel, K., Franzmann, A., Burkart, M. and Schulz, M.:
DOSAGE STRENGTH IS ASSOCIATED WITH MEDICATION PERSISTENCE WITH GINGKO BILOBA DRUG PRODUCTS.
BMC Complement. Altern. Med. 2013; 13 (1): 278 [DOI: 10.1186/1472-6882-13-278]. Epub October 24, 2013.
PubMed
Full text    PDF



2012

Quinzler, R., Ude, M., Franzmann, A., Feldt, S., Schüssel, K., Leuner, K., Müller,
W.E., Dippel.F.-W. and Schulz, M.:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type 2 diabetic patients: comparison of insulin glargine with NPH insulin.
Int. J. Clin. Pharmacol. Ther. 2012; 50 (1): 24–32.
PubMed

Eickhoff, C., Hämmerlein, A., Griese, N. and Schulz, M.:
Nature and frequency of drug-related problems in self-medicatioN (OVER-THE-COUNTER DRUGS) in daily community pharmacy practice in Germany.
Pharmacoepidemiol. Drug Saf. 2012; 21 (3): 254
-260 [DOI: 10.1002/pds.2241]. Epub September 28, 2011.
PubMed 

Hohmann, C., Eickhoff, C., Radziwill, R. and Schulz, M.:
Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: A multicenter evaluation involving pharmacy interns.
Infection 2012; 40 (2): 131–137 [DOI: 10.1007/s15010-011-0204-7]. Epub October 15, 2011.
PubMed 

Feldt, S., Schüssel, K., Quinzler, R., Franzmann, A., Czeche, S., Ludwig, W.-D. and Schulz, M.:
INCIDENCE OF THYROID HORMONE THERAPY IN PATIENTS TREATED WITH SUNITINIB OR SORAFENIB: A COHORT STUDY.
Eur. J. Cancer 2012; 48 (7): 974
-981 [DOI:10.1016/j.ejca.2012.01.036]. Epub February 28, 2012.
PubMed     Full text

Schulz, M., Iwersen-Bergmann, S., Andresen, H. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF NEARLY 1,000 DRUGS AND OTHER XENOBIOTICS.
Critical Care 2012; 16: R136 [DOI:10.1186/cc11441]. Epub July 26, 2012
[Total accesses as of 5 Sep 2018: 17472].
PubMed
Full text (including suppl. material)

Additional file 1 

2011

Krüger, M., Griese, N. and Schulz, M.:
Medikationsmanagement für Menschen mit Diabetes.
[Home medication review for patients with diabetes].
Diabetes Stoffw. Herz 2011; 20 (4): 219–226.
Online 

Hohmann, C., Eickhoff, C., Kämmerer, W. and Schulz, M.:
Compliance with antithrombotic guidelines in surgery patients in German hospitals: A multicenter study involving pharmacy interns.
Clin. Appl. Thromb. Hemost. 2012; 18 (3): 299–304 [DOI: 10.1177/1076029611412368]. Epub July 6, 2011.
PubMed 

Ude, M., Schüssel. K., Quinzler, R., Leuner, K., Müller, W.E. and Schulz, M.:
Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective Study using the DAPI database.
J. Hypertens. 2011; 29 (9): 1837–1845 [DOI: 10.1097/HJH.0b013e32834942be]. Epub July 6, 2011.
PubMed

Hohmann, C. Eickhoff, C., Klotz, J.M., Schulz, M. and Radziwill, R.:
DEVELOPMENT OF A CLASSIFICATION SYSTEM FOR DRUG-RELATED PROBLEMS IN THE HOSPITAL SETTING (APS-Doc) AND ASSESSMENT OF THE INTER-RATER RELIABILITY.
J. Clin. Pharm. Ther. 2012; 37 (3): 276–281 [DOI: 10.1111/j.1365-2710.2011.01281.x]. Epub July 26, 2011.
PubMed

Laufs, U., Böhm, M., Kroemer, H.K., Schüssel, K., Griese, N. and Schulz, M.:
Strategien zur Verbesserung der Einnahmetreue von Medikamenten.
[Strategies to Improve Medication Adherence].
Dtsch. Med. Wochenschr. 2011; 136 (31-32): 1616–1621. Epub August 1, 2011.
PubMed



2010

Hämmerlein, A., Müller, U. and Schulz, M.:
VERSORGUNGSMANAGEMENT FÜR MENSCHEN MIT ASTHMA – EINBINDUNG DER APOTHEKER
[Involving pharmacists in the management of asthma patients].
Z. Evid. Fortbild. Qual. Gesundh. wesen 2010; 104 (2): 92–98 [DOI : 10.1016/j.zefq.2009.07.007].
PubMed

Hämmerlein, A., Müller, U. and Schulz M.:
Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients.
J. Eval. Clin. Pract. 2011; 17 (1): 61–70 [DOI: 10.1111/j.1365-2753.2010.01369.x]. Epub Aug 30, 2010.
PubMed

2009

Hämmerlein, A. and Schulz, M.:
Co-authors of the German National Disease Management Guideline (Nationale VersorgungsLeitlinie (NVL)) ASTHMA, 2nd ed. 2009.
Eds.: Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF).
Revision in:
Dtsch. Ärztebl. 2011; 108 (11): A-596 / B-484 / C-484.
NVL Asthma



2008

Schüssel, K., Quinzler, R., Czeche, S. and Schulz, M.:
AKTUELLE VEORDNUNGEN VON COX-2-HEMMERN IN DEUTSCHLAND
[Contemporary precriptions of COX-2 inhibitors in Germany].
Internist. Praxis 2008; 48 (4): 837–850.
Full text



2007

Gerdemann, A., Griese, N. and Schulz, M.:
PHARMACY INTERNS ON THE WARD – A PILOT STUDY.
Pharm. World Sci. 2007; 29 (1):
3438 (DOI: 10.1007/s11096-005-5044-z].
PubMed

Rajska-Neumann, A., Wieczorowska-Tobis, K., Schulz, M., Breborowicz, A., Grzeskowiak, E. and Oreopoulos D.G.:
Duplicate use of angiotensin-converting enzyme (ACE) inhibitors in a community-dwelling elderly population in Poland.
Arch. Gerontol. Geriatr. 2007; 44 (Suppl. 1): 295–301.
PubMed

Bertsche, T., Hämmerlein, A. and Schulz, M.:
GERMAN NATIONAL DRUG INFORMATION SERVICE: USER SATISFACTION AND POTENTIAL POSITIVE PATIENT OUTCOMES.
Pharm. World. Sci. 2007; 29 (3): 167–172 [DOI: 10.1007/s11096-006-9041-7].
PubMed

Hämmerlein, A., Griese, N., and Schulz, M.:
Survey of Drug-related Problems Identified by Community Pharmacies.
Ann. Pharmacother. 2007; 41 (11): 18251832 [DOI: 10.1345/aph.1K207].
PubMed 



2006

Eickhoff, C. and Schulz, M.:
PHARMACEUTICAL CARE IN COMMUNITY PHARMACIES: PRACTICE AND RESEARCH IN GERMANY.
Ann. Pharmacother. 2006; 40 (4): 729–735 [DOI: 10.1345/aph.1G458].
PubMed

Schulz, M., Graefe, T., Stuby, K., Andresen, H., Kupfermann, N. and Schmoldt, A.:
Case report: Acute unintentional carbachol intoxication.
Critical Care 2006; 10: R84 [DOI:10.1186/cc4937].
Full text

Schulz, M., Hämmerlein, A., Hinkel, U., Weis, G. and Gillissen, A.:
SAFETY AND USAGE PATTERN OF AN OVER-THE-COUNTER AMBROXOL COUGH SYRUP:
A COMMUNITY PHARMACY-BASED COHORT STUDY.
Int. J. Clin. Pharmacol. Ther. 2006; 44 (9): 409–421.
PubMed

Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
EVALUATION DER DURCHFÜHRUNG VON GLUKOSESELBSTKONTROLLEN IN APOTHEKEN (EDGAr)
[Evaluation of self-monitoring of blood glucose in pharmacies - EDGAr].
Diabetes Stoffw. Herz 2006; 15 (4): 9–17.

Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
COMMUNITY PHARMACY-BASED INTERVENTION TO IMPROVE SELF-MONITORING OF BLOOD GLUCOSE IN TYPE 2 DIABETIC PATIENTS.
Pharm. Pract. 2006; 4 (4): 195–203.
Full text

Schuessel, K. and Schulz, M.:
PRESCRIBING OF COX-2-INHIBITORS IN GERMANY AFTER SAFETY WARNINGS AND MARKET WITHDRAWALS.
Pharmazie 2006; 61 (10): 878–886.
PubMed

Van Mil, J.W.F. and Schulz, M.:
A review of Pharmaceutical Care in Community Pharmacy in Europe.
Harvard Health Policy Review 2006; 7 (1): 155
168.
Full text



2005

Berger, K, Eickhoff, C. and Schulz, M.:
Counselling quality in community pharmacies:
Implementation of the pseudo customer methodology in Germany
.
J. Clin. Pharm. Ther. 2005; 30 (1): 45–57.
PubMed

Mangiapane, S., Schulz, M., Mühlig, S., Ihle, P., Schubert, I. and Waldmann, H.-C.:
COMMUNITY PHARMACY-BASED PHARMACEUTICAL CARE FOR ASTHMA PATIENTS.
Ann. Pharmacother. 2005; 39 (11): 1817–1822.
PubMed



2004

Van Mil, J.W.F., Schulz, M. and Tromp, Th.F.J.:
PHARMACEUTICAL CARE, EUROPEAN DEVELOPMENTS IN CONCEPTS, IMPLEMENTATION, TEACHING, AND RESEARCH: A REVIEW.
Pharm. World Sci. 2004; 26 (6): 303–311.
PubMed



2003

Hauner, H., Maxion-Bergemann, S., Müller, E., Schulz, M., Huppertz, E. and Bergemann, R.:
DMP DIABETES MELLITUS: SIMULATION DER BEHANDLUNGSERGEBNISSE VERSCHIEDENER LEITLINIEN.
Ein neues Diabetes mellitus Modell (DMM).
[Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines.
A new diabetes mellitus model (DMM)].
Dtsch. Med. Wochenschr.
2003; 128 (21): 1167–1172.
PubMed

Schulz, M. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 800 DRUGS AND OTHER XENOBIOTICS.
Pharmazie 2003; 58 (7): 447–474.
PubMed



2002

Azodi, K., Himstedt, S., Hinrichs, A., Krüger, M., Schrader, S. and Schulz, M.:
TESTING OF THE READABILITY OF PACKAGE LEAFLETS AS AN INITIAL STEP UNDER THE PHARMACEUTICAL CARE INITIATIVE TOWARDS INCREASING THE SAFETY OF MEDICINAL PRODUTCS.
Pharm. Ind. 2002; 64 (11): 1119–1125.


2001


Schulz, M., Schmoldt, A., Donn, F. and Becker, H.: 
LACK OF METHEMOGLOBINEMIA WITH FLUTAMIDE. 
Ann. Pharmacother. 2001
; 35 (1): 21–25. 
PubMed 

Brockmeyer, R., Steindl, L., Behrens, I., Gnekow, S., Verheyen, F. and Schulz, M.
Testing of the readability of package inserts at a community pharmacy.
Pharm. Ind. 2001; 63 (2): 114–119. 
Online 

Schulz, M., Verheyen, F., Mühlig, S., Müller, J.M., Mühlbauer, K., Knop-Schneickert, E., Petermann, F. and Bergmann, K.-C.: 
PHARMACEUTICAL CARE SERVICES FOR ASTHMA PATIENTS. 
A CONTROLLED INTERVENTION STUDY.
J. Clin. Pharmacol. 2001; 41 (6): 668–676. 
PubMed 
Reports in, among others: Pharm. J. 2001; 267 (14 July): 43 and
FIP News 2001; 2 (9): 2. 


2000

Stein, S., Schmoldt, A. and Schulz, M.
FATAL INTOXICATION WITH MELPERONE.
Forensic Sci. Int. 2000; 113 (1-3): 409–413. 
PubMed 

Seibt, K., Schulz, M. and Hensel, F.J.: 
MEINUNGEN UND EINSTELLUNGEN ZUM THEMA IMPFEN BEI NIEDERGELASSENEN ÄRZTEN, OFFIZINAPOTHEKERN UND IHREM PERSONAL SOWIE AKTUELLER IMPFSTATUS DIESER GRUPPEN
[Opinions and attitudes on the topic of vaccination of established physicians, pharmacists and their personnel and current vaccination status of these groups]. 
Gesundheitswesen 2000; 62 (7): 376–382. 
PubMed 


1999

Iwersen-Bergmann, S., Schmoldt, A., Püschel, K. and Schulz, M.
VERGIFTUNGS- UND TODESFÄLLE DURCH SUBSTITUTIONSMITTEL IM UMFELD VON SUBSTITUIERTEN DROGENKONSUMENTEN
[Fatal and non-fatal poisonings with substitute drugs in the environment of substituted addicts].
Rechtsmedizin 1999; 9 (3): 90–93. 
Abstract  
Abstract (German) 


1997

Schulz, M. and Schmoldt, A.: 
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 500 DRUGS.
Pharmazie 1997; 52 (12): 895–911. 
PubMed 


1996

Scholz, J., Steinfath, M. and Schulz, M.
CLINICAL PHARMACOKINETICS OF ALFENTANIL, FENTANYL, AND SUFENTANIL:
AN UPDATE. 
Clin. Pharmacokinet. 1996; 31 (4): 275–292. 
PubMed 


1995

Scholz, J., Schulz, M., Steinfath, M., Höver, S. and Bause, H.: 
FLUCONAZOLE IS REMOVED BY CONTINUOUS VENOVENOUS HEMOFILTRATION IN A
LIVER TRANSPLANT PATIENT.
J. Mol. Med. 1995; 73 (3): 145–147. 
PubMed  

Schmoldt, A., Sagowski, C., Iwersen, S. and Schulz, M.
HEMMUNG DER ADH-AKTIVITÄT DES MAGENS DURCH H2-REZEPTORENBLOCKER
[Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists]. 
Rechtsmedizin 1995; 5: 73–77. 

Fox, J.M., unter Mitarbeit von Menges, K., Coper, H., Doenicke, A., Ferner, U.J., Gaertner, H.J., Hoffmeister, F., Janke, W., Janzen, R.W.C., Kanowski, S., Kreiskott, H., Müller-Oerlinghausen, B., Netter, P., Oelschläger, H., Poser, W., Radke, J., Rüther, E. and Schulz, M.
KOMBINATIONSARZNEIMITTEL AUS PARACETAMOL PLUS ACETYLSALICYLSÄURE: NUTZEN UND RISIKEN
[Fixed-dosed combinations of paracetamol(acetaminophen) and aspirin: benefits and risks].  
Schmerz 1995; 9: 273–285.  


1994

Schulz, M. and Schmoldt, A.: 
SUCCESSFUL PHYSOSTIGMINE TREATMENT OF ACUTE DOTHIEPIN INTOXICATION.
Pharmazie 1994; 49 (8): 614. 
PubMed  

Scholz, J., Bause, H., Schulz, M., Klotz, U., Krishna, D.R., Pohl, S. and Schulte am Esch, J.:
PHARMACOKINETICS AND EFFECTS ON INTRACRANIAL PRESSURE OF SUFENTANIL IN HEAD TRAUMA PATIENTS. 
Br. J. Clin. Pharmacol. 1994; 38 (4): 369–372. 
PubMed 

Schulz, M. and Schmoldt, A.:
ZUSAMMENSTELLUNG THERAPEUTISCHER UND TOXISCHER
PLASMAKONZENTRATIONSBEREICHE VON ARZNEISTOFFEN. 
Anaesthesist 1994; 43 (12): 835–844. 
PubMed   


1993

Schulz, M. and Schmoldt, A.:
NON-INTERACTION OF RANITIDINE WITH HYDROXYLATION OF DICLOFENAC IN RAT AND HUMAN LIVER MICROSOM
ES.
Pharmazie 1993; 48 (8): 625–626.
PubMed


1992

Schulz, M. and Schmoldt, A.: 
KONZENTRATIONEN VON CEFOTIAM IM KOLONGEWEBE UND PLASMA NACH APPLIKATION ZUR PERIOPERATIVEN ANTIBIOTIKA-PROPHYLAXE
[Concentrations of cefotiam in colon tissue and plasma after application for perioperative antibiotic prophylaxis].
Zeitschr. Antimikrobiol. Antineoplast. Chemother. 1992; 10: 33–37. 


1991

Schulz, M., Wischhusen, F. and Schmoldt, A.: 
THERAPEUTISCHE UND TOXISCHE PLASMAKONZENTRATIONEN SOWIE ELIMINATIONSHALBWERTSZEITEN GEBRÄUCHLICHER ARZNEISTOFFE.
Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1991; 26 (1): 37–43. 
PubMed  
Schulz, M. and Schmoldt, A.: Pharm. Ztg. Wiss. 1991; 136 (4): 87–94 [extended reprint].  


1989

Donn, F., Bruns, T., von Meyerinck, L., Schulz, M., Becker, W.-M., Becker, H. and
Klosterhalfen, H.: 
MONOCLONAL ANTIBODY THAT
DEFINES THE PROSTATE SPECIFIC ANTIGEN.
Prostate 1989; 14 (3): 237–249. 
PubMed  

Schulz, M., Meyer, W., Schmitz, W., Scholz, J. and Schmoldt, A.: 
BETA-REZEPTORENBLOCKER: GRUNDLAGEN ZUR ARZNEIMITTELAUSWAHL FÜR EINE RATIONALE THERAPIE
[Beta receptor blockers.
Principles for drug selection for rational therapy]. 
Med. Monatsschr. Pharm. 1989; 12 (8): 237
244.  
PubMed  
Reprint in: Arzneimittelther. 1989; 7 (6): 169–176. 

Schulz, M. and Schmoldt, A.: 
DETERMINATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN HUMAN PLASMA
BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. 
Pharm. Ztg. Wiss. 1989; 134 (2): 41–44. 


1988

Frese, J.H., Rohland, L., Schulz, M. and Schmoldt, A.: 
INTOXIKATION MIT GALLOPAMIL.
Verlauf und Therapie
[
Gallopamil poisoning. Its course and therapy]. 
Dtsch.
Med. Wochenschr. 1988; 113 (19): 770–772. 
PubMed  

Schulz, M.
INTERAKTIONEN AUSGEWÄHLTER HISTAMIN H2-REZEPTORANTAGONISTEN MIT DEM
CYTOCHROM P-450-SYSTEM UND MÖGLICHE AUSWIRKUNGEN AUF DIE PHARMAKO-
KINETIK NICHTSTEROIDALER ANTIRHEUMATIKA. 
[Interactions of selected histamine H2-receptor antagonists with the cytochrome P-450 system and potential effects on the pharmacokinetics of non-steroidal antiinflammatory drugs].
PhD thesis (Dr. rer. nat.). University Hamburg. August 1988. 

Schulz, M., Schmoldt, A., Donn, F. and Becker, H.: 
THE PHARMACOKINETICS OF FLUTAMIDE AND ITS MAJOR METABOLITES
AFTER A SINGLE ORAL DOSE AND DURING CHRONIC TREATMENT. 
Eur. J. Clin. Pharmacol. 1988; 34 (6): 633–636. 
PubMed   

Schulz, M. and Schmoldt, A.: 
ON THE SULPHOXIDATION OF CIMETIDINE AND ETINTIDINE BY RAT AND HUMAN LIVER MICROSOMES. 
Xenobiotica 1988; 18 (8): 983–989.
PubMed   


1987


Schulz, M.
and Schmoldt, A.: 
INTERACTIONS OF THE HISTAMINE H2-RECEPTOR ANTAGONIST ETINTIDINE WITH RAT
LIVER CYTOCHROME P-450: A COMPARISON WITH CIMETIDINE. 
Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 336 (4): 453–458. 
PubMed